PRAS40 alleviates neurotoxic prion peptide-induced apoptosis via mTOR-AKT signaling. 2017

Wei Yang, and Li-Feng Yang, and Zhi-Qi Song, and Syed Zahid Ali Shah, and Yong-Yong Cui, and Chao-Si Li, and Hua-Fen Zhao, and Hong-Li Gao, and Xiang-Mei Zhou, and De-Ming Zhao
National Animal Transmissible Spongiform Encephalopathy Laboratory and Key Laboratory of Animal Epidemiology and Zoonosis of Ministry of Agriculture, College of Veterinary Medicine and State Key Laboratory of Agrobiotechnology, China Agricultural University, Beijing, China.

OBJECTIVE The proline-rich Akt substrate of 40-kDa (PRAS40) protein is a direct inhibitor of mTORC1 and an interactive linker between the Akt and mTOR pathways. The mammalian target of rapamycin (mTOR) is considered to be a central regulator of cell growth and metabolism. Several investigations have demonstrated that abnormal mTOR activity may contribute to the pathogenesis of several neurodegenerative disorders and lead to cognitive deficits. METHODS Here, we used the PrP peptide 106-126 (PrP106-126 ) in a cell model of prion diseases (also known as transmissible spongiform encephalopathies, TSEs) to investigate the mechanisms of mTOR-mediated cell death in prion diseases. RESULTS We have shown that, upon stress caused by PrP106-126 , the mTOR pathway activates and contributes to cellular apoptosis. Moreover, we demonstrated that PRAS40 down-regulates mTOR hyperactivity under stress conditions and alleviates neurotoxic prion peptide-induced apoptosis. The effect of PRAS40 on apoptosis is likely due to an mTOR/Akt signaling. CONCLUSIONS PRAS40 inhibits mTORC1 hyperactivation and plays a key role in protecting cells against neurotoxic prion peptide-induced apoptosis. Thus, PRAS40 is a potential therapeutic target for prion disease.

UI MeSH Term Description Entries
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010750 Phosphoproteins Phosphoprotein
D011257 Pregnancy Proteins Proteins produced by organs of the mother or the PLACENTA during PREGNANCY. These proteins may be pregnancy-specific (present only during pregnancy) or pregnancy-associated (present during pregnancy or under other conditions such as hormone therapy or certain malignancies.) Placental Proteins,Proteins, Placental,Proteins, Pregnancy
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal
D017096 Prion Diseases A group of genetic, infectious, or sporadic degenerative human and animal nervous system disorders associated with abnormal PRIONS. These diseases are characterized by conversion of the normal prion protein to an abnormal configuration via a post-translational process. In humans, these conditions generally feature DEMENTIA; ATAXIA; and a fatal outcome. Pathologic features include a spongiform encephalopathy without evidence of inflammation. The older literature occasionally refers to these as unconventional SLOW VIRUS DISEASES. (From Proc Natl Acad Sci USA 1998 Nov 10;95(23):13363-83) Dementias, Transmissible,Spongiform Encephalopathies, Transmissible,Transmissible Dementias,Encephalopathies, Spongiform, Transmissible,Human Transmissible Spongiform Encephalopathies, Inherited,Inherited Human Transmissible Spongiform Encephalopathies,Prion Disease,Prion Protein Diseases,Prion-Associated Disorders,Prion-Induced Disorder,Prion-Induced Disorders,Transmissible Spongiform Encephalopathies,Dementia, Transmissible,Disorder, Prion-Induced,Disorders, Prion-Induced,Encephalopathies, Transmissible Spongiform,Encephalopathy, Transmissible Spongiform,Prion Induced Disorder,Prion Protein Disease,Spongiform Encephalopathy, Transmissible,Transmissible Dementia,Transmissible Spongiform Encephalopathy
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D017382 Reactive Oxygen Species Molecules or ions formed by the incomplete one-electron reduction of oxygen. These reactive oxygen intermediates include SINGLET OXYGEN; SUPEROXIDES; PEROXIDES; HYDROXYL RADICAL; and HYPOCHLOROUS ACID. They contribute to the microbicidal activity of PHAGOCYTES, regulation of SIGNAL TRANSDUCTION and GENE EXPRESSION, and the oxidative damage to NUCLEIC ACIDS; PROTEINS; and LIPIDS. Active Oxygen Species,Oxygen Radical,Oxygen Radicals,Pro-Oxidant,Reactive Oxygen Intermediates,Active Oxygen,Oxygen Species, Reactive,Pro-Oxidants,Oxygen, Active,Pro Oxidant,Pro Oxidants,Radical, Oxygen

Related Publications

Wei Yang, and Li-Feng Yang, and Zhi-Qi Song, and Syed Zahid Ali Shah, and Yong-Yong Cui, and Chao-Si Li, and Hua-Fen Zhao, and Hong-Li Gao, and Xiang-Mei Zhou, and De-Ming Zhao
January 2022, BioMed research international,
Wei Yang, and Li-Feng Yang, and Zhi-Qi Song, and Syed Zahid Ali Shah, and Yong-Yong Cui, and Chao-Si Li, and Hua-Fen Zhao, and Hong-Li Gao, and Xiang-Mei Zhou, and De-Ming Zhao
June 2012, American journal of physiology. Endocrinology and metabolism,
Wei Yang, and Li-Feng Yang, and Zhi-Qi Song, and Syed Zahid Ali Shah, and Yong-Yong Cui, and Chao-Si Li, and Hua-Fen Zhao, and Hong-Li Gao, and Xiang-Mei Zhou, and De-Ming Zhao
February 2022, Biomolecules,
Wei Yang, and Li-Feng Yang, and Zhi-Qi Song, and Syed Zahid Ali Shah, and Yong-Yong Cui, and Chao-Si Li, and Hua-Fen Zhao, and Hong-Li Gao, and Xiang-Mei Zhou, and De-Ming Zhao
January 2017, International journal of clinical and experimental pathology,
Wei Yang, and Li-Feng Yang, and Zhi-Qi Song, and Syed Zahid Ali Shah, and Yong-Yong Cui, and Chao-Si Li, and Hua-Fen Zhao, and Hong-Li Gao, and Xiang-Mei Zhou, and De-Ming Zhao
January 2016, American journal of cancer research,
Wei Yang, and Li-Feng Yang, and Zhi-Qi Song, and Syed Zahid Ali Shah, and Yong-Yong Cui, and Chao-Si Li, and Hua-Fen Zhao, and Hong-Li Gao, and Xiang-Mei Zhou, and De-Ming Zhao
August 2020, European journal of pharmacology,
Wei Yang, and Li-Feng Yang, and Zhi-Qi Song, and Syed Zahid Ali Shah, and Yong-Yong Cui, and Chao-Si Li, and Hua-Fen Zhao, and Hong-Li Gao, and Xiang-Mei Zhou, and De-Ming Zhao
February 2017, Chemico-biological interactions,
Wei Yang, and Li-Feng Yang, and Zhi-Qi Song, and Syed Zahid Ali Shah, and Yong-Yong Cui, and Chao-Si Li, and Hua-Fen Zhao, and Hong-Li Gao, and Xiang-Mei Zhou, and De-Ming Zhao
July 2015, Biochemical pharmacology,
Wei Yang, and Li-Feng Yang, and Zhi-Qi Song, and Syed Zahid Ali Shah, and Yong-Yong Cui, and Chao-Si Li, and Hua-Fen Zhao, and Hong-Li Gao, and Xiang-Mei Zhou, and De-Ming Zhao
March 2022, Shock (Augusta, Ga.),
Wei Yang, and Li-Feng Yang, and Zhi-Qi Song, and Syed Zahid Ali Shah, and Yong-Yong Cui, and Chao-Si Li, and Hua-Fen Zhao, and Hong-Li Gao, and Xiang-Mei Zhou, and De-Ming Zhao
March 2020, Experimental and therapeutic medicine,
Copied contents to your clipboard!